ORIGIN INC.

origin-inc-logo

Origin Inc. is one of the leading private Industrial company of IT in the northern part of state Odisha, India. Founded in 2010 by Dibya Ranjan Giri. Origin is a global provider of IT solutions and staffing, offers organizations efficient and cost effective options for software development services.

#SimilarOrganizations #People #Website #More

ORIGIN INC.

Social Links:

Industry:
Civil Engineering Information And Communications Technology (ICT) Information Services Information Technology

Founded:
2010-05-16

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.originww.com

Total Employee:
101+

Status:
Active

Contact:
07205246767


Similar Organizations

dataspartan-logo

DataSpartan

The leading Artificial Intelligence and Data Science experts - Delivering the Impossible

device-origin-inc-logo

Device Origin, Inc.

W.A.L.D.O. is a next generation consumer location platform powering higher levels of customer conversion. Wherever they go, There we are.


Current Advisors List

dibya-ranjan-giri_image

Dibya Ranjan Giri Founder @ Origin Inc.
Advisor
2010-05-16

Current Employees Featured

dibya-ranjan-giri_image

Dibya Ranjan Giri
Dibya Ranjan Giri Chief Executive Officer @ Origin Inc.
Chief Executive Officer
2010-05-16

Founder


dibya-ranjan-giri_image

Dibya Ranjan Giri

Official Site Inspections

http://www.originww.com

  • Host name: 151.101.194.159
  • IP address: 151.101.194.159
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Origin Inc."

About Us - Origin Life Sciences

CONTACT. Origin Life Sciences, Inc. 2 Research Way Princeton, New Jersey 08540 USA. Phone: +1 609 250 6000 Email: [email protected]See details»

Origin Home - Origin Life Sciences

In the human body, nitric oxide (NO) is a naturally-occurring signaling molecule that is known to regulate blood flow (1,9-11), modulate inflammation (1-4), stimulate tissue regeneration (3,9), โ€ฆSee details»

Origin, Inc. - VentureRadar

Website: https://www.originww.com. Develops and commercializes novel, patented medical technology based on Nobel prize-winning research for point-of-care therapeutic molecule โ€ฆSee details»

Origin Life Sciences - PitchBook

Mar 23, 2020 Origin Life Sciences General Information Description. Origin Life Sciences Inc is a clinical-stage biotechnology company that has been developing a proprietary patented high โ€ฆSee details»

Origin Life Sciences, Inc. (OLSI) Company Profile & Overview

Origin Life Sciences is a clinical-stage biotechnology company that has been developing a proprietary patented high-energy plasma device that generates nitric oxide (โ€œNOโ€) in the form โ€ฆSee details»

Origin Company Profile - Office Locations, Competitors, Revenue โ€ฆ

Origin is a clinical-stage biotechnology company focusing on nitric oxide (NO) and its generation via thermal plasma. It provides IonoJet, a technology for the targeted delivery of NO, produced โ€ฆSee details»

Origin, Inc. - VentureRadar

Similar Companies: Proteros Germany Privately Held Proteros is a privately-held company with expertise in structure-based drug discovery powered by discovery engine tailored to unlock โ€ฆSee details»

Terry Treadwell - Chief Clinical Officer Designate at โ€ฆ

He has served as Vice-President of the Wound and Lymphedema Council of the World Health Organization since 2011. He has served as a Member of the Safety and Data Committees for four national and international research firms. He โ€ฆSee details»

Origin - Crunchbase Company Profile & Funding

Origin is a privately-held, clinical-stage biotechnology company developing a medical technology to deliver therapeutic molecules. It is mainly for the targeted delivery of nitric oxide, used to โ€ฆSee details»

Board of Directors - Origin Life Sciences - originww.com

CONTACT. Origin Life Sciences, Inc. 2 Research Way Princeton, New Jersey 08540 USA. Phone: +1 609 250 6000 Email: [email protected]See details»

Origin Life Sciences Abstract Accepted for Presentation at

Nov 6, 2024 The poster for this breakout session will be presented in Poster Session 3 on Wednesday, August 28, 2024 by Dr. Terry Treadwell, Vice President of the Wound and โ€ฆSee details»

Originโ„ข Announces First 50 Patients Randomized, and Full

Jun 1, 2017 Contact Data Contacts Origin Mike Preston [email protected] +1 845 494 5049 Betsy Hanna [email protected] +1 609 250 6004 MBS Value Partners Lisa โ€ฆSee details»

Origin Life Sciences, Inc. (OLSI) - Stock Analysis

About OLSI. Origin Life Sciences is a clinical-stage biotechnology company that has been developing a proprietary patented high-energy plasma device that generates nitric oxide โ€ฆSee details»

Terms and Policies - Origin Life Sciences - originww.com

If you believe that someone under those ages has disclosed personal information to us through our Site, please report this to us immediately by emailing us at: [email protected] or โ€ฆSee details»

Origin, Inc. Announces First Randomized Patients Into Phase IIb ...

Mar 22, 2017 [email protected] +1 845 494 5049 Betsy Hanna [email protected] +1 609 250 6004 FTI Consulting Brett Pollard / Matthew Cole / Hanna Skeppner โ€ฆSee details»

Origine - Buy Organic, Regenerative Spices and Natural Botanical ...

Buy Organic Regenerative Herbs, Spices and Natural Ingredients from Origine.com. We ethically craft pure and natural botanicals from Indonesia to improve global health, wellness, and โ€ฆSee details»

OriginLab - Origin and OriginPro - Data Analysis and Graphing โ€ฆ

Over 1 Million registered users across corporations, universities and government research labs worldwide, rely on Origin to import, graph, explore, analyze and interpret their data.See details»

Origin

Access the best EA games, exclusive deals, and cloud saves with the Origin app, your ultimate gaming destination.See details»

Technology Platform - Origin Life Sciences

CLINICAL STUDIES. To date, our technology has been studied in (i) animal safety studies that were completed between 2013 and 2016; (ii) a single-center study of 40 patients in 2013 to โ€ฆSee details»

linkstock.net © 2022. All rights reserved